Carsten Behrens
Carsten Behrens
Verified email at - Homepage
Cited by
Cited by
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
M Egholm, O Buchardt, L Christensen, C Behrens, SM Freier, DA Driver, ...
Nature 365 (6446), 566-568, 1993
Synthesis of peptide nucleic acid monomers containing the four natural nucleobases: thymine, cytosine, adenine, and guanine and their oligomerization
KL Dueholm, M Egholm, C Behrens, L Christensen, HF Hansen, T Vulpius, ...
The Journal of Organic Chemistry 59 (19), 5767-5773, 1994
Engineered CHO cells for production of diverse, homogeneous glycoproteins
Z Yang, S Wang, A Halim, MA Schulz, M Frodin, SH Rahman, ...
Nature biotechnology 33 (8), 842-844, 2015
Small-molecule agonists for the glucagon-like peptide 1 receptor
LB Knudsen, D Kiel, M Teng, C Behrens, D Bhumralkar, JT Kodra, ...
Proceedings of the National Academy of Sciences 104 (3), 937-942, 2007
Glycoprotein labeling using engineered variants of galactose oxidase obtained by directed evolution
JB Rannes, A Ioannou, SC Willies, G Grogan, C Behrens, SL Flitsch, ...
Journal of the American Chemical Society 133 (22), 8436-8439, 2011
Peptide nucleic acids containing adenine or guanine recognize thymine and cytosine in complementary DNA sequences
M Egholm, C Behrens, L Christensen, RH Berg, PE Nielsen, O Buchardt
Journal of the Chemical Society, Chemical Communications, 800-801, 1993
Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor
M Teng, MD Johnson, C Thomas, D Kiel, JN Lakis, T Kercher, S Aytes, ...
Bioorganic & Medicinal Chemistry Letters 17 (19), 5472-5478, 2007
AS Jorgensen, IT Christensen, JT Kodra, C Sams, C Behrens, P Madsen, ...
US Patent 20,020,143,186, 2002
Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptor
JT Kodra, AS Jørgensen, B Andersen, C Behrens, CL Brand, ...
Journal of medicinal chemistry 51 (17), 5387-5396, 2008
Glucagon antagonists/inverse agonists
J Lau, IT Christensen, P Madsen, P Bloch, C Behrens, JT Kodra, ...
US Patent 6,881,746, 2005
An enantioselective ring expansion route leading to furanose and pyranose nucleosides featuring spirodiketopiperazines at the anomeric position
LA Paquette, S Brand, C Behrens
The Journal of Organic Chemistry 64 (6), 2010-2025, 1999
New β-alanine derivatives are orally available glucagon receptor antagonists
J Lau, C Behrens, UG Sidelmann, LB Knudsen, B Lundt, C Sams, ...
Journal of Medicinal Chemistry 50 (1), 113-128, 2007
Modified Proteins
C Behrens, PW Garibay, M Zundel
US Patent App. 11/664,199, 2008
Berg, RH, Kim, SK, Nordkn, B. & Nielsen, PE (1993)
M Egholm, O Buchardt, L Christensen, C Behrens, SM Freier, DA Driver
Nature 365, 556-568, 0
Modified proteins
C Behrens
US Patent App. 12/439,221, 2010
Synthesis of a Hoechst 32258 analogue amino acid building block for direct incorporation of a fluorescent, high-affinity DNA binding motif into peptides
C Behrens, N Harrit, PE Nielsen
Bioconjugate Chemistry 12 (6), 1021-1027, 2001
PEGylated factor VII glycoforms
NK Klausen, S Bjorn, C Behrens, PW Garibay
US Patent 8,053,410, 2011
Pegylated factor VII glycoforms
N Klausen, S Bjorn, C Behrens, P Garibay
US Patent App. 10/609,701, 2005
Glucagon antagonists/inverse agonists
J Lau, P Madsen, C Sams, C Behrens, J Vagner, IT Christensen, BF Lundt, ...
US Patent 6,503,949, 2003
Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties
P Madsen, JT Kodra, C Behrens, E Nishimura, CB Jeppesen, L Pridal, ...
Journal of medicinal chemistry 52 (9), 2989-3000, 2009
The system can't perform the operation now. Try again later.
Articles 1–20